🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/10/2013 | 44,48 | 45,01 | 44,44 | 45,01 | +1,29% | 1,29% | 11.635.630 |
| 15/10/2013 | 44,39 | 44,69 | 44,29 | 44,44 | -0,39% | 0,88% | 14.840.728 |
| 14/10/2013 | 44,66 | 44,92 | 44,31 | 44,61 | -1,14% | 1,37% | 21.666.876 |
| 11/10/2013 | 45,25 | 45,31 | 44,99 | 45,12 | -0,42% | 0,72% | 10.745.668 |
| 10/10/2013 | 45,42 | 45,45 | 44,81 | 45,31 | +0,47% | 1,41% | 18.090.995 |
| 09/10/2013 | 45,51 | 45,63 | 44,98 | 45,11 | -1,01% | 1,43% | 16.090.363 |
| 08/10/2013 | 45,65 | 45,94 | 45,46 | 45,56 | -0,29% | 1,07% | 14.693.694 |
| 07/10/2013 | 45,73 | 46,02 | 45,50 | 45,70 | -0,70% | 1,15% | 9.637.198 |
| 04/10/2013 | 46,06 | 46,15 | 45,74 | 46,02 | -0,27% | 0,87% | 12.126.198 |
| 03/10/2013 | 46,01 | 46,52 | 45,80 | 46,15 | -0,02% | 1,56% | 18.759.724 |
| 02/10/2013 | 46,23 | 46,33 | 45,92 | 46,15 | -0,76% | 0,89% | 14.646.114 |
| 01/10/2013 | 46,68 | 46,98 | 45,94 | 46,51 | +2,37% | 2,21% | 28.651.482 |
| 30/09/2013 | 45,46 | 45,68 | 45,12 | 45,43 | -0,38% | 1,22% | 17.023.712 |
| 27/09/2013 | 45,39 | 45,72 | 45,12 | 45,60 | +0,23% | 1,30% | 11.014.794 |
| 26/09/2013 | 45,59 | 45,80 | 45,33 | 45,50 | +0,02% | 1,03% | 10.753.633 |
| 25/09/2013 | 45,49 | 45,79 | 45,25 | 45,49 | +0,29% | 1,20% | 11.901.402 |
| 24/09/2013 | 45,45 | 46,01 | 45,34 | 45,35 | -0,31% | 1,47% | 13.939.029 |
| 23/09/2013 | 45,60 | 45,86 | 45,36 | 45,50 | -0,69% | 1,09% | 13.210.774 |
| 20/09/2013 | 46,12 | 46,18 | 45,68 | 45,81 | -0,52% | 1,10% | 29.303.128 |
| 19/09/2013 | 46,25 | 46,27 | 45,90 | 46,05 | -0,29% | 0,80% | 9.775.744 |
| 18/09/2013 | 45,62 | 46,48 | 45,45 | 46,18 | +0,81% | 2,26% | 14.681.118 |
| 17/09/2013 | 45,91 | 46,02 | 45,74 | 45,81 | -0,37% | 0,60% | 8.073.058 |
| 16/09/2013 | 46,04 | 46,23 | 45,90 | 45,98 | +0,84% | 0,73% | 9.880.754 |
| 13/09/2013 | 45,69 | 45,79 | 45,49 | 45,60 | -0,13% | 0,67% | 8.049.688 |
| 12/09/2013 | 45,61 | 45,78 | 45,47 | 45,66 | -0,60% | 0,69% | 9.958.515 |
| 11/09/2013 | 45,83 | 46,29 | 45,76 | 45,94 | +0,33% | 1,15% | 14.021.297 |
| 10/09/2013 | 45,67 | 46,18 | 45,67 | 45,78 | +0,50% | 1,13% | 32.287.413 |
| 09/09/2013 | 45,42 | 45,66 | 45,31 | 45,55 | +0,53% | 0,78% | 30.580.850 |
| 06/09/2013 | 45,39 | 45,63 | 44,90 | 45,31 | -0,04% | 1,60% | 27.944.815 |
| 05/09/2013 | 45,60 | 45,60 | 45,10 | 45,33 | -0,36% | 1,11% | 8.277.314 |